Literature DB >> 22304906

Finding a target for resveratrol.

Ruth I Tennen1, Eriko Michishita-Kioi, Katrin F Chua.   

Abstract

Despite resveratrol's well-documented health benefits, its mechanism of action remains controversial. In particular, the direct molecular target of resveratrol has been elusive. Park et al. now show that resveratrol directly inhibits cAMP-dependent phosphodiesterases, triggering a cascade of events that converge on the important energy-sensing metabolic regulators AMPK, SIRT1, and PGC-1α.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Year:  2012        PMID: 22304906     DOI: 10.1016/j.cell.2012.01.032

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  32 in total

1.  Resveratrol improves motoneuron function and extends survival in SOD1(G93A) ALS mice.

Authors:  Renzo Mancuso; Jaume del Valle; Laura Modol; Anna Martinez; Ana B Granado-Serrano; Omar Ramirez-Núñez; Mercé Pallás; Manel Portero-Otin; Rosario Osta; Xavier Navarro
Journal:  Neurotherapeutics       Date:  2014-04       Impact factor: 7.620

Review 2.  Resveratrol supplementation: Where are we now and where should we go?

Authors:  Marta G Novelle; Devin Wahl; Carlos Diéguez; Michel Bernier; Rafael de Cabo
Journal:  Ageing Res Rev       Date:  2015-01-24       Impact factor: 10.895

Review 3.  Resveratrol for the Management of Diabetes and its Downstream Pathologies.

Authors:  Moola Joghee Nanjan; James Betz
Journal:  Eur Endocrinol       Date:  2014-02-28

4.  Potent Inhibition of HIV-1 Replication in Resting CD4 T Cells by Resveratrol and Pterostilbene.

Authors:  Chi N Chan; Benjamin Trinité; David N Levy
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

5.  Trans-resveratrol boronic acid exhibits enhanced anti-proliferative activity on estrogen-dependent MCF-7 breast cancer cells.

Authors:  Venkata Mahidhar Yenugonda; Yali Kong; Tushar B Deb; Yonghong Yang; Rebecca B Riggins; Milton L Brown
Journal:  Cancer Biol Ther       Date:  2012-08-01       Impact factor: 4.742

6.  Resveratrol-loaded nanoparticles based on poly(epsilon-caprolactone) and poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) blend for prostate cancer treatment.

Authors:  Vanna Sanna; Imtiaz Ahmad Siddiqui; Mario Sechi; Hasan Mukhtar
Journal:  Mol Pharm       Date:  2013-09-04       Impact factor: 4.939

Review 7.  Role of Silent Information Regulator 1 (SIRT1) in Regulating Oxidative Stress and Inflammation.

Authors:  Vivek Singh; Saba Ubaid
Journal:  Inflammation       Date:  2020-10       Impact factor: 4.092

8.  Inverse regulation of the cytosolic Ca²⁺ buffer parvalbumin and mitochondrial volume in muscle cells via SIRT1/PGC-1α axis.

Authors:  Sylvie Ducreux; Patrick Gregory; Beat Schwaller
Journal:  PLoS One       Date:  2012-09-13       Impact factor: 3.240

9.  Hypoxia, AMPK activation and uterine artery vasoreactivity.

Authors:  K L Skeffington; J S Higgins; A D Mahmoud; A M Evans; A N Sferruzzi-Perri; A L Fowden; H W Yung; G J Burton; D A Giussani; L G Moore
Journal:  J Physiol       Date:  2015-07-31       Impact factor: 6.228

Review 10.  Human umbilical cord mesenchymal stem cells in type 2 diabetes mellitus: the emerging therapeutic approach.

Authors:  Andreia Gomes; Pedro Coelho; Raquel Soares; Raquel Costa
Journal:  Cell Tissue Res       Date:  2021-05-29       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.